Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / C••••••• C••••••• R•••••••

W•••••••• C••••••• T••••• Enters Definitive Agreement to Acquire C••••••• C••••••• R•••••••

Add-on acquisitionannouncedadd-onannounced Jan 20, 2026Fact
What happened
Target
C••••••• C••••••• R•••••••
Platform
W•••••••• C••••••• T•••••add-on basis: W•••••••• is a portfolio company of K•••••••.
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
9 named
Buy side
  • N••• D•••Board appointeeconfirmed
    “Following the close of the transaction, N••• D•••, Chairman of the Board of C•••••••, will join W••••••••’s Board of Directors, and N•• M•••••, President and CEO of C•••••••, will join W••••••••’s executive leadership team.”
  • W•••••••• C••••••• T•••••Platformconfirmed
    “W•••••••• is a portfolio company of K•••••••.”
  • K••••••• • C••••••Sponsorconfirmed
    “W•••••••• is a portfolio company of K•••••••.”
Advisory side
  • G•••••••• T••••••Legal adviserconfirmed
    “G•••••••• T••••••, LLP served as legal counsel to W••••••••.”
  • S•••• A•••••••Legal adviserconfirmed
    “BofA S••••••••• served as exclusive advisor and S•••• A••••••• served as legal counsel to C•••••••.”
  • B••• S••••••••• I•••Sell-side adviserconfirmed
    “BofA S••••••••• served as exclusive advisor and S•••• A••••••• served as legal counsel to C•••••••.”
Side not stated
  • A••••••• M••••••••Managementconfirmed
    ““Bringing W•••••••• and C••••••• together elevates our capabilities in oncology and provides a new solution for our collective customers,” said A••••••• M••••••••, Chief Executive Officer of W••••••••.”
  • N•• M•••••Managementconfirmed
    “By joining forces, C••••••• brings our specialized early phase oncology expertise together with W••••••••’s strength in late phase development, expanding our global footprint and delivering differentiated oncology solutions globally.” said N•• M•••••, President and Chief Executive Officer of C••••••”
  • C••••••• C••••••• R•••••••Targetconfirmed
    “W•••••••• C••••••• T••••• Enters Definitive Agreement to Acquire C••••••• C••••••• R•••••••”
Evidence
“W•••••••• C••••••• T••••• Enters Definitive Agreement to Acquire C••••••• C••••••• R•••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
W•••••••• C••••••• T••••• Enters Definitive Agreement to Acquire C••••••• C••••••• R•••••• | Private Equity Intelligence | DFX